Efficacy Study of EVO301 in Moderate to Severe Atopic Dermatitis

Dose-ranging Study of Nemolizumab in Atopic Dermatitis

NCT03100344 ·Status: COMPLETED ·Phase: PHASE2

An Evaluation of LEO 138559 in Adults With Moderate to Severe Atopic Dermatitis.

NCT04922021 ·Status: COMPLETED ·Phase: PHASE2

A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis

NCT05995964 ·Status: RECRUITING ·Phase: PHASE2

Phase 2a Study to Assess the Efficacy,Safety and Tolerability of GIA632 in Adult Participants With Moderate to Severe Atopic Dermatitis

NCT07220577 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Efficacy and Safety of MEDI3506 in Adult Subjects With Atopic Dermatitis

NCT04212169 ·Status: COMPLETED ·Phase: PHASE2

A Phase 2 Study of E6005 in Patients With Atopic Dermatitis

NCT01461941 ·Status: COMPLETED ·Phase: PHASE2

Safety, Tolerability and PK of ATTO-3712 in Healthy Volunteers and Patients With Atopic Dermatitis

NCT07205081 ·Status: RECRUITING ·Phase: PHASE1

A Study Investigating the Effect of EDP1815 in the Treatment of Mild, Moderate and Severe Atopic Dermatitis

NCT05121480 ·Status: COMPLETED ·Phase: PHASE2

Efalizumab for Eczema

NCT00146003 ·Status: COMPLETED ·Phase: PHASE2

A Phase 1/2 Study of E6005 in Pediatric Subjects With Atopic Dermatitis

NCT02094235 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Study in Healthy Participants and Participants With Moderate Atopic Dermatitis & Optionally, Moderate Psoriasis, and/or Mild Asthma

NCT04927195 ·Status: COMPLETED ·Phase: PHASE1

A Study to Assess the Efficacy and Safety of MSTT1041A in Participants With Moderate to Severe Atopic Dermatitis

NCT03747575 ·Status: COMPLETED ·Phase: PHASE2

Study to Evaluate Safety and Tolerability of PF-07242813 in Healthy Participants and Participants With Atopic Dermatitis

NCT04668066 ·Status: COMPLETED ·Phase: PHASE1

A Study of TAVO101 in Atopic Dermatitis Patients

NCT06176040 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Dose Escalation Trial of CM310 in Patients With Moderate-to-Severe Atopic Dermatitis (AD)

NCT04893941 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Phase 2b Study to Evaluate the Efficacy and Safety of ISB 830 in Adults With Moderate to Severe Atopic Dermatitis

NCT03568162 ·Status: COMPLETED ·Phase: PHASE2

Evaluate Efficacy and Safety of Repeat Subcutaneous Doses of FB825 in Adults With Moderate-to-Severe Atopic Dermatitis

NCT06397911 ·Status: RECRUITING ·Phase: PHASE2

Study to Evaluate Safety & Efficacy of Topical ATx201 OINTMENT in Adolescents and Adults With Mild to Moderate AD

NCT04339985 ·Status: COMPLETED ·Phase: PHASE2

The Study of CM326 in Moderate-to-severe Atopic Dermatitis

NCT05671432 ·Status: UNKNOWN ·Phase: PHASE2

Efficacy and Safety Study of Apremilast in Subjects With Moderate to Severe Atopic Dermatitis

NCT02087943 ·Status: COMPLETED ·Phase: PHASE2

A Phase III Clinical Study of QY201 Tablet in Subjects With Moderate to Severe Atopic Dermatitis.

NCT07180511 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE3

A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab Monotherapy Compared With Placebo in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis

NCT06130566 ·Status: COMPLETED ·Phase: PHASE3

Evaluation of Upadacitinib in Adolescent and Adult Patients With Moderate to Severe Atopic Dermatitis (Eczema)

NCT03569293 ·Status: COMPLETED ·Phase: PHASE3

Evaluate Efficacy, PK, and Safety of FB825 in Adults With Atopic Dermatitis

NCT04413942 ·Status: UNKNOWN ·Phase: PHASE2

Subcutaneously CM310/Placebo in Patients With Moderate-to-Severe Atopic Dermatitis (AD)

NCT04805411 ·Status: COMPLETED ·Phase: PHASE2